|
1
|
Mamelak AN and Jacoby DB: Targeted
delivery of antitumoral therapy to glioma and other malignancies
with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv.
4:175–186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kleihues P, Soylemezoglu F, Schäuble B,
Scheithauer BW and Burger PC: Histopathology, classification, and
grading of gliomas. Glia. 15:211–221. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bleeker FE, Molenaar RJ and Leenstra S:
Recent advances in the molecular understanding of glioblastoma. J
Neurooncol. 108:11–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pollack IF, Finkelstein SD, Woods J,
Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay JL
and Sposto R; Children's Cancer Group, : Expression of p53 and
prognosis in children with malignant gliomas. N Engl J Med.
346:420–427. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirose Y, Berger MS and Pieper RO: p53
effects both the duration of G2/M arrest and the fate of
temozolomide-treated human glioblastoma cells. Cancer Res.
61:1957–1963. 2001.PubMed/NCBI
|
|
8
|
Pyrko P, Schönthal AH, Hofman FM, Chen TC
and Lee AS: The unfolded protein response regulator GRP78/BiP as a
novel target for increasing chemosensitivity in malignant gliomas.
Cancer Res. 67:9809–9816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hegi ME, Diserens AC, Gorlia T, Hamou MF,
de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani
L, et al: MGMT gene silencing and benefit from temozolomide in
glioblastoma. N Engl J Med. 352:997–1003. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujiwara S, Nakagawa K, Harada H, Nagato
S, Furukawa K, Teraoka M, Seno T, Oka K, Iwata S and Ohnishi T:
Silencing hypoxia-inducible factor-1alpha inhibits cell migration
and invasion under hypoxic environment in malignant gliomas. Int J
Oncol. 30:793–802. 2007.PubMed/NCBI
|
|
11
|
Zagzag D, Lukyanov Y, Lan L, Ali MA,
Esencay M, Mendez O, Yee H, Voura EB and Newcomb EW:
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in
glioblastoma: Implications for angiogenesis and glioma cell
invasion. Lab Invest. 86:1221–1232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roth W, Isenmann S, Nakamura M, Platten M,
Wick W, Kleihues P, Bähr M, Ohgaki H, Ashkenazi A and Weller M:
Soluble decoy receptor 3 is expressed by malignant gliomas and
suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer
Res. 61:2759–2765. 2001.PubMed/NCBI
|
|
13
|
Osada H, Tokunaga T, Nishi M, Hatanaka H,
Abe Y, Tsugu A, Kijima H, Yamazaki H, Ueyama Y and Nakamura M:
Overexpression of the neuropilin 1 (NRP1) gene correlated with poor
prognosis in human glioma. Anticancer Res. 24:547–552.
2004.PubMed/NCBI
|
|
14
|
Zhang L, Shen A, Ke Q, Zhao W, Yan M and
Cheng C: Spy1 is frequently overexpressed in malignant gliomas and
critically regulates the proliferation of glioma cells. J Mol
Neurosci. 47:485–494. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guan X, Vengoechea J, Zheng S, Sloan AE,
Chen Y, Brat DJ, O'Neill BP, de Groot J, Yust-Katz S, Yung WK, et
al: Molecular subtypes of glioblastoma are relevant to lower grade
glioma. PLoS One. 9:e912162014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai H, Chen H, Yi T, Daimon CM, Boyle JP,
Peers C, Maudsley S and Martin B: VennPlex-a novel Venn diagram
program for comparing and visualizing datasets with differentially
regulated datapoints. PLoS One. 8:e533882013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harris MA, Clark J, Ireland A, Lomax J,
Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C,
et al: The Gene Ontology (GO) database and informatics resource.
Nucleic Acids Res. 32(Database Issue): D258–D261. 2004.PubMed/NCBI
|
|
19
|
Kanehisa M, Goto S, Kawashima S, Okuno Y
and Hattori M: The KEGG resource for deciphering the genome.
Nucleic Acids Res. 32(Database Issue): D277–D280. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jensen LJ, Kuhn M, Stark M, Chaffron S,
Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, et
al: STRING 8-a global view on proteins and their functional
interactions in 630 organisms. Nucleic Acids Res. 37(Database
Issue): D412–D416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43(Database Issue): D447–D452. 2014.PubMed/NCBI
|
|
22
|
Saito R, Smoot ME, Ono K, Ruscheinski J,
Wang PL, Lotia S, Pico AR, Bader GD and Ideker T: A travel guide to
Cytoscape plugins. Nat Methods. 9:1069–1076. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nepusz T, Yu H and Paccanaro A: Detecting
overlapping protein complexes in protein-protein interaction
networks. Nat Methods. 9:471–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Davis AP, Grondin CJ, Lennon-Hopkins K,
Saraceni-Richards C, Sciaky D, King BL, Wiegers TC and Mattingly
CJ: The Comparative Toxicogenomics Database's 10th year
anniversary: Update 2015. Nucleic Acids Res. 43(Database Issue):
D914–D920. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lakka SS, Gondi CS, Yanamandra N, Olivero
WC, Dinh DH, Gujrati M and Rao JS: Inhibition of cathepsin B and
MMP-9 gene expression in glioblastoma cell line via RNA
interference reduces tumor cell invasion, tumor growth and
angiogenesis. Oncogene. 23:4681–4689. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun C, Wang Q, Zhou H, Yu S, Simard AR,
Kang C, Li Y, Kong Y, An T, Wen Y, et al: Antisense MMP-9 RNA
inhibits malignant glioma cell growth in vitro and in vivo.
Neurosci Bull. 29:83–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gondi CS, Lakka SS, Dinh DH, Olivero WC,
Gujrati M and Rao JS: Downregulation of uPA, uPAR and MMP-9 using
small, interfering, hairpin RNA (siRNA) inhibits glioma cell
invasion, angiogenesis and tumor growth. Neuron Glia Biol.
1:165–176. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang M, Wang T, Liu S, Yoshida D and
Teramoto A: The expression of matrix metalloproteinase-2 and-9 in
human gliomas of different pathological grades. Brain Tumor Pathol.
20:65–72. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hormigo A, Gu B, Karimi S, Riedel E,
Panageas KS, Edgar MA, Tanwar MK, Rao JS, Fleisher M, DeAngelis LM
and Holland EC: YKL-40 and matrix metalloproteinase-9 as potential
serum biomarkers for patients with high-grade gliomas. Clin Cancer
Res. 12:5698–5704. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ku BM, Lee YK, Ryu J, Jeong JY, Choi J,
Eun KM, Shin HY, Kim DG, Hwang EM, Yoo JC, et al: CHI3L1 (YKL-40)
is expressed in human gliomas and regulates the invasion, growth
and survival of glioma cells. Int J Cancer. 128:1316–1326. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tanwar MK, Gilbert MR and Holland EC: Gene
expression microarray analysis reveals YKL-40 to be a potential
serum marker for malignant character in human glioma. Cancer Res.
62:4364–4368. 2002.PubMed/NCBI
|
|
32
|
Ulrich TA, de Juan Pardo EM and Kumar S:
The mechanical rigidity of the extracellular matrix regulates the
structure, motility, and proliferation of glioma cells. Cancer Res.
69:4167–4174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bellail AC, Hunter SB, Brat DJ, Tan C and
Van Meir EG: Microregional extracellular matrix heterogeneity in
brain modulates glioma cell invasion. Int J Biochem Cell Biol.
36:1046–1069. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Carlson MR, Pope WB, Horvath S, Braunstein
JG, Nghiemphu P, Tso CL, Mellinghoff I, Lai A, Liau LM, Mischel PS,
et al: Relationship between survival and edema in malignant
gliomas: Role of vascular endothelial growth factor and neuronal
pentraxin 2. Clin Cancer Res. 13:2592–2598. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Johansson M, Brännström T, Bergenheim AT
and Henriksson R: Spatial expression of VEGF-A in human glioma. J
Neurooncol. 59:1–6. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gong J, Zhu S, Zhang Y and Wang J:
Interplay of VEGFa and MMP2 regulates invasion of glioblastoma.
Tumor Biol. 35:11879–11885. 2014. View Article : Google Scholar
|
|
37
|
Liang J, Piao Y, Holmes L, Fuller GN,
Henry V, Tiao N and de Groot JF: Neutrophils promote the malignant
glioma phenotype through S100A4. Clin Cancer Res. 20:187–198. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takenaga K, Nygren J, Zelenina M, Ohira M,
Iuchi T, Lukanidin E, Sjöquist M and Kozlova EN: Modified
expression of Mts1/S100A4 protein in C6 glioma cells or surrounding
astrocytes affects migration of tumor cells in vitro and in vivo.
Neurobiol Dis. 25:455–463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cheng SX, Tu Y and Zhang S: FoxM1 promotes
glioma cells progression by up-regulating Anxa1 expression. PLoS
One. 8:e723762013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Festa M, Caputo M, Cipolla C, D'Acunto C,
Rossi A, Tecce M and Capasso A: The involvement of xanthohumol in
the expression of annexin in human malignant glioblastoma cells.
Open Biochem J. 7:1–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
